The blood–brain barrier: a help and a hindrance
Brain · 07.07.2025 · 148 (7) · 2262-2282
DOI: 10.1093/brain/awaf068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, online erschienen am 19.02.2025. Verfasst von Ruslan Rust und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Neuroscience, University of Southern California, Los Angeles, CA 90033, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Brain. Die Arbeit wurde bisher 105-mal zitiert (Crossref) und nennt 339 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, Keck School of Medicine, Swiss National Science Foundation.
Abstract (Originalsprache)
The blood–brain barrier (BBB) is a specialized vascular structure that protects the brain micro-environment from toxins and pathogens in the blood. At the same time, the BBB presents a significant challenge for drug development, as it restricts the entry of most therapeutics into the brain. In this review, we first examine recent findings on the molecular and cellular architecture of the BBB, emphasizing the diverse mechanisms that facilitate the transport and exchange of molecules between the blood and the brain. We discuss current knowledge on the heterogeneity of the BBB along the arteriovenous axis and across different brain regions. Then, we explore the molecular and functional changes in the BBB that occur during normal ageing, neurodegeneration and acute brain injuries, and how prolonged BBB impairment affects transport mechanisms and disease progression. Additionally, we discuss novel developments in drug delivery strategies to transport small molecules, biologicals or cellular therapeutics across the BBB. Finally, we examine therapeutic opportunities to restore the BBB and discuss future directions in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Neuroscience, University of Southern California, Los Angeles, CA 90033, USA.
- Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 3K7, Canada.
- Institute for Regenerative Medicine, University of Zurich, Schlieren, Zurich 8952, Switzerland.
ORCID-Profile: Ruslan Rust, Hao Yin, Beatriz Achón Buil, Kassandra Kisler
Förderung
- NINDS NIH HHS
- Keck School of Medicine
- Swiss National Science Foundation
Zitieren
APA
Rust, R., Yin, H., Achón Buil, B., Sagare, A. P., & Kisler, K. (2025). The blood–brain barrier: a help and a hindrance. Brain, 148(7), 2262-2282. https://doi.org/10.1093/brain/awaf068
Vancouver
Rust R, Yin H, Achón Buil B, Sagare AP, Kisler K. The blood–brain barrier: a help and a hindrance. Brain. 2025;148(7):2262-2282. doi:10.1093/brain/awaf068
BibTeX
@article{Rust2025,
author = {Rust, Ruslan and Yin, Hao and Achón Buil, Beatriz and Sagare, Abhay P and Kisler, Kassandra},
title = {The blood–brain barrier: a help and a hindrance},
journal = {Brain},
year = {2025},
volume = {148},
number = {7},
pages = {2262--2282},
doi = {10.1093/brain/awaf068}
}
EUVIMED